Healthcare Hims & Hers stock price soars following weight loss drug deal Gabrielle M. Etzel · March 9, 2026 11:04 am
In Focus Your doctor is overstretched. Drug ads help you show up prepared Bethany Mandel · March 3, 2026 8:00 am
Community and Family GLP-1 medications expose “body positivity” movement’s lies Kimberly Ross · February 13, 2026 6:00 am
Faith, Freedom, and Self-Reliance Competition, not price controls, just slashed GLP-1 prices Sally Pipes · November 30, 2025 9:31 am
News Joe Concha weighs in on Ozempic debate, Sydney Sweeney, and political rhetoric Adisa Hargett-Robinson · November 7, 2025 11:48 am
Healthcare Trump makes deal to lower prices of obesity drugs from Eli Lilly and Novo Nordisk Gabrielle M. Etzel · November 6, 2025 12:04 pm
In Focus Junk science on the menu: How ‘Fat Studies’ endangers public health Peter Laffin · September 4, 2025 8:00 am
Healthcare FDA commissioner looks to get in front of disease with nutrition and eliminating environmental toxins Jenny Goldsberry · May 25, 2025 4:56 pm
Healthcare Novo Nordisk applies for FDA approval in tightening race for weight loss pill Gabrielle M. Etzel · April 22, 2025 11:07 am
Business
